Supriya Lifescience Ltd
NSE:SUPRIYA
Supriya Lifescience Ltd
NSE:SUPRIYA
Price:
632.2
INR
0.62%
Market Closed
Market Cap:
₹50.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Supriya Lifescience Ltd
NSE:SUPRIYA
|
IN |
|
C
|
Cutia Therapeutics
HKEX:2487
|
CN |
|
Truly International Holdings Ltd
HKEX:732
|
HK |
|
Liberty Latin America Ltd
NASDAQ:LILA
|
US |
|
B
|
Biogen Inc
LSE:0R1B
|
US |
|
AGP Corp
TSE:9377
|
JP |
|
Digital China Information Service Co Ltd
SZSE:000555
|
CN |
|
A
|
Access Group Holdings Co Ltd
TSE:7042
|
JP |
|
H
|
Human Creation Holdings Inc
TSE:7361
|
JP |
|
Pinnacle Investment Management Group Ltd
ASX:PNI
|
AU |
Income Statement
Earnings Waterfall
Supriya Lifescience Ltd
Supriya Lifescience Ltd
Income Statement
Supriya Lifescience Ltd
Supriya Lifescience Ltd
Currency: INR
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Interest Expense |
27
|
0
|
0
|
0
|
17
|
0
|
0
|
0
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
5 300
N/A
|
8 562
+62%
|
7 436
-13%
|
8 487
+14%
|
4 609
-46%
|
4 916
+7%
|
5 195
+6%
|
5 545
+7%
|
5 704
+3%
|
5 990
+5%
|
6 250
+4%
|
6 706
+7%
|
6 965
+4%
|
6 809
-2%
|
7 147
+5%
|
7 355
+3%
|
|
| Gross Profit | |||||||||||||||||
| Cost of Revenue |
(2 138)
|
(3 390)
|
(2 957)
|
(3 470)
|
(2 070)
|
(1 930)
|
(2 078)
|
(2 110)
|
(2 575)
|
(2 231)
|
(2 075)
|
(2 146)
|
(2 485)
|
(1 944)
|
(2 041)
|
(2 035)
|
|
| Gross Profit |
3 163
N/A
|
5 172
+64%
|
4 479
-13%
|
5 017
+12%
|
2 540
-49%
|
2 986
+18%
|
3 118
+4%
|
3 434
+10%
|
3 129
-9%
|
3 759
+20%
|
4 175
+11%
|
4 559
+9%
|
4 480
-2%
|
4 866
+9%
|
5 106
+5%
|
5 319
+4%
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(1 123)
|
(1 965)
|
(1 671)
|
(2 098)
|
(1 301)
|
(1 463)
|
(1 803)
|
(1 855)
|
(1 490)
|
(2 011)
|
(2 106)
|
(2 255)
|
(1 987)
|
(2 589)
|
(2 768)
|
(2 939)
|
|
| Selling, General & Administrative |
(977)
|
(1 503)
|
(1 235)
|
(1 381)
|
(1 148)
|
(583)
|
(629)
|
(658)
|
(1 300)
|
(723)
|
(745)
|
(767)
|
(1 708)
|
(831)
|
(879)
|
(928)
|
|
| Research & Development |
(17)
|
0
|
0
|
0
|
(12)
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(40)
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
(101)
|
(179)
|
(160)
|
(189)
|
(118)
|
(129)
|
(139)
|
(149)
|
(158)
|
(165)
|
(173)
|
(183)
|
(204)
|
(222)
|
(241)
|
(260)
|
|
| Other Operating Expenses |
(28)
|
(283)
|
(277)
|
(528)
|
(23)
|
(751)
|
(1 036)
|
(1 048)
|
(20)
|
(1 123)
|
(1 188)
|
(1 305)
|
(35)
|
(1 535)
|
(1 648)
|
(1 751)
|
|
| Operating Income |
2 040
N/A
|
3 207
+57%
|
2 808
-12%
|
2 919
+4%
|
1 238
-58%
|
1 522
+23%
|
1 314
-14%
|
1 579
+20%
|
1 639
+4%
|
1 748
+7%
|
2 070
+18%
|
2 304
+11%
|
2 493
+8%
|
2 277
-9%
|
2 338
+3%
|
2 380
+2%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
44
|
64
|
(200)
|
(210)
|
79
|
(263)
|
(30)
|
(25)
|
77
|
(19)
|
(19)
|
(19)
|
92
|
(19)
|
(19)
|
(18)
|
|
| Non-Reccuring Items |
3
|
0
|
0
|
0
|
(67)
|
0
|
0
|
0
|
(67)
|
0
|
0
|
0
|
(89)
|
0
|
0
|
(5)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
(15)
|
20
|
40
|
65
|
(14)
|
101
|
99
|
104
|
8
|
99
|
100
|
90
|
(11)
|
103
|
105
|
110
|
|
| Pre-Tax Income |
2 072
N/A
|
3 291
+59%
|
2 648
-20%
|
2 774
+5%
|
1 235
-55%
|
1 360
+10%
|
1 383
+2%
|
1 658
+20%
|
1 657
0%
|
1 828
+10%
|
2 151
+18%
|
2 376
+10%
|
2 485
+5%
|
2 361
-5%
|
2 424
+3%
|
2 467
+2%
|
|
| Net Income | |||||||||||||||||
| Tax Provision |
(554)
|
(861)
|
(709)
|
(740)
|
(336)
|
(429)
|
(382)
|
(454)
|
(466)
|
(476)
|
(576)
|
(631)
|
(605)
|
(580)
|
(600)
|
(614)
|
|
| Income from Continuing Operations |
1 518
|
2 430
|
1 939
|
2 034
|
899
|
931
|
1 001
|
1 204
|
1 191
|
1 352
|
1 575
|
1 745
|
1 880
|
1 781
|
1 824
|
1 853
|
|
| Net Income (Common) |
1 518
N/A
|
2 430
+60%
|
1 939
-20%
|
2 034
+5%
|
899
-56%
|
931
+4%
|
1 001
+8%
|
1 204
+20%
|
1 191
-1%
|
1 352
+14%
|
1 575
+16%
|
1 745
+11%
|
1 880
+8%
|
1 781
-5%
|
1 824
+2%
|
1 853
+2%
|
|
| EPS (Diluted) |
18.86
N/A
|
30.22
+60%
|
24.15
-20%
|
25.22
+4%
|
11.16
-56%
|
11.58
+4%
|
12.45
+8%
|
14.97
+20%
|
14.8
-1%
|
16.8
+14%
|
19.48
+16%
|
21.7
+11%
|
23.35
+8%
|
22.11
-5%
|
22.7
+3%
|
23.01
+1%
|
|
Switch to:
Switch to:
See Also
Discover More
